Uzara® (Tablets, Solution, Syrup) Instructions for Use
ATC Code
A07X (Other antidiarrheal drugs)
Clinical-Pharmacological Group
Antidiarrheal phytopharmaceutical
Pharmacotherapeutic Group
Antidiarrheal agent of plant origin
Pharmacological Action
An antidiarrheal agent of plant origin. The mechanism of the antiperistaltic action of Uzara is based on the stimulation of the sympathetic nervous system, resulting in a weakening of intestinal motility.
In addition to inhibiting the motility of the digestive tract, Uzara® has an antispasmodic, antisecretory, astringent, and enveloping effect.
Indications
Nonspecific acute and chronic diarrhea
- Diarrhea associated with allergic reactions;
- Diarrhea caused by psychoemotional factors;
- Diarrhea caused by disorders of metabolism and nutrient absorption;
- “traveler’s diarrhea” due to changes in diet and habitual food intake.
As an auxiliary agent for diarrhea of infectious origin.
ICD codes
| ICD-10 code | Indication |
| A09 | Other and unspecified gastroenteritis and colitis of infectious origin |
| K59.1 | Functional diarrhea |
| ICD-11 code | Indication |
| 1A40.Z | Infectious gastroenteritis or colitis, unspecified |
| DD91.2 | Functional diarrhea |
| DD93.Y | Other specified functional gastrointestinal disorders in infants, toddlers and school-age children |
| DD9Z | Functional gastrointestinal disorders, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Tablets
Orally, regardless of meals.
Adults and children over 12 years old initial dose on the first day – 5 tablets (200 mg) as a single dose, on subsequent days – 1 tablet (40 mg) 3-6 times a day until stool normalizes. Tablets should be taken with a small amount of liquid.
Syrup
Orally, regardless of meals.
Adults initial dose on the first day – 25 ml of syrup as a single dose, on subsequent days – 5 ml 3-6 times/day until stool normalizes.
School-age children (from 7 to 16 years old) initial dose on the first day 5-7 ml of syrup, on subsequent days 3-4 ml 3-6 times/day.
Preschool children (from 2 to 6 years old) 1-2 ml of syrup 3-6 times/day.
Children from 1 to 2 years old 0.5 ml of syrup 3 times/day.
Adverse Reactions
Allergic reactions.
Contraindications
- Treatment with cardiac glycosides;
- Pregnancy;
- Lactation period;
- Children under 1 year of age;
- Hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
Experimental studies have not revealed any teratogenic or mutagenic properties of Uzara. To date, no developmental defects have been reported with the use of the drug.
Since clinical experience with the drug in pregnant and lactating women is very limited, the use of Uzara during pregnancy and lactation is not indicated.
Special Precautions
If the duration of diarrhea exceeds 2 days, is accompanied by high body temperature, or if there are blood impurities in the stool, it is necessary to consult a doctor immediately.
Use in pediatrics
In children, the drug should be used under medical supervision to avoid overdose.
In children under 6 years of age, oral rehydration agents must be used as the main therapy. The course of treatment should not exceed 7 days.
Drug Interactions
With simultaneous use with calcium preparations, saluretics, or during long-term therapy with cortisol preparations, cardiac arrhythmias may occur.
Storage Conditions
Store at a temperature not exceeding 25°C (77°F). Keep out of reach of children.
Shelf Life
Shelf life – 5 years.
Dispensing Status
By prescription.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Oral solution 40 mg/1 ml: bottle 30 ml or 100 ml
Marketing Authorization Holder
Stada Arzneimittel, AG (Germany)
Dosage Form
| Uzara® | Oral solution 40 mg/1 ml: bottle 30 ml or 100 ml |
Dosage Form, Packaging, and Composition
Oral solution transparent, from light brown to brown in color, slight opalescence is allowed.
| 1 ml | |
| Uzara root dry extract (4-6:1) (calculated as uzarin) | 40 mg |
Excipients : ethanol 96%, disodium edetate dihydrate, purified water up to 1 ml.
30 ml – dark glass bottles with a dropper (1) in a set with a measuring cap – cardboard boxes.
100 ml – dark glass bottles with a dropper (1) in a set with a measuring cap – cardboard boxes.
Film-coated tablets, 40 mg: 20 or 50 pcs.
Marketing Authorization Holder
Stada Arzneimittel, AG (Germany)
Manufactured By
Rottendorf Pharma, GmbH (Germany)
Dosage Form
| Uzara® | Film-coated tablets, 40 mg: 20 or 50 pcs. |
Dosage Form, Packaging, and Composition
Film-coated tablets white, round, biconvex; the tablet core is from light brown to brown in color with white specks.
| 1 tablet | |
| Uzara root dry extract (4-6:1) (calculated as uzarin) | 40 mg |
Excipients : wheat starch, lactose monohydrate, carob bean starch, talc, colloidal anhydrous silicon dioxide, magnesium stearate.
Tablet coating composition: calcium carbonate, glucose syrup (dry substance), magnesium oxide, corn starch (Snowflake 06598), castor oil, sucrose, shellac, talc, titanium dioxide E171, glycol mountain wax.
10 pcs. – blister packs (2) – cardboard boxes.
10 pcs. – blister packs (5) – cardboard boxes.
Syrup 7.56 mg/1 ml: bottle 100 ml in set with measuring cap
Marketing Authorization Holder
Stada Arzneimittel, AG (Germany)
Dosage Form
| Uzara® | Syrup 7.56 mg/1 ml: bottle 100 ml in set with measuring cap |
Dosage Form, Packaging, and Composition
Syrup transparent to opalescent, from yellowish to brownish in color, with a characteristic odor.
| 1 ml | |
| Uzara root dry extract (4.5-6.2:1) | 7.56 mg |
Excipients : propylene glycol, macrogolglycerol hydroxystearate, cola flavor, dextrose (glucose) monohydrate, liquid dextrose (glucose), purified water.
100 ml – dark glass bottles (1) in a set with a measuring cap – cardboard boxes.
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Kagocel pills 12mg, 30pcs
Fenotropil pills 100mg, 60pcs
Picamilon pills 50mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Nootropil pills 800mg, 30pcs
Phenibut-Vertex pills 250mg, 20pcs
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
Belosalic, lotion solution for external use spray 100ml
Daivobet, ointment, 30g
Ingavirin capsules 90mg, 10pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Cortexin, 10mg, 5ml, 10pcs
Arbidol, capsules 100mg, 40pcs
OKI, sachets 80mg 2g, 12pcs 